Next Article in Journal
Quality of Rye Plants (Secale cereale) as Affected by Agronomic Biofortification with Iodine
Next Article in Special Issue
Convective Drying of Purple Basil (Ocimum basilicum L.) Leaves and Stability of Chlorophyll and Phenolic Compounds during the Process
Previous Article in Journal
The Effect of Different Agrotechnical Treatments on the Establishment of Miscanthus Hybrids in Soil Contaminated with Trace Metals
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical and Biological Evaluation of Amazonian Medicinal Plant Vouacapoua americana Aubl

by
Serhat Sezai Çiçek
1,*,
Anna Laís Pfeifer Barbosa
1,
Arlette Wenzel-Storjohann
2,
Jorge Federico Orellana Segovia
3,
Roberto Messias Bezerra
4,
Frank Sönnichsen
5,
Christian Zidorn
1,
Isamu Kanzaki
6 and
Deniz Tasdemir
2,7
1
Department of Pharmaceutical Biology, Kiel University, Gutenbergstraße 76, 24118 Kiel, Germany
2
Research Unit Marine Natural Products Chemistry, GEOMAR Centre for Marine Biotechnology (GEOMAR-Biotech), GEOMAR Helmholtz Centre for Ocean Research Kiel, Am Kiel-Kanal 44, 24106 Kiel, Germany
3
Ecoregional Research Unit, Brazilian Agricultural Research Corporation, Rod. JK, Km 5, Macapá 68903-419, AP, Brazil
4
Laboratory of Bioprospection and Atomic Absorption, Federal University of Amapá, Rod. JK, Macapá 68903-419, AP, Brazil
5
Otto Diels Institute for Organic Chemistry, Kiel University, Otto-Hahn-Platz 4, 24118 Kiel, Germany
6
Laboratory of Bioprospection, Darcy Ribeiro Campus, University of Brasilia, Brasilia 70910-900, DF, Brazil
7
Faculty of Mathematics and Natural Sciences, Kiel University, Christian-Albrechts-Platz 4, 24118 Kiel, Germany
*
Author to whom correspondence should be addressed.
Plants 2023, 12(1), 99; https://doi.org/10.3390/plants12010099
Submission received: 20 November 2022 / Revised: 3 December 2022 / Accepted: 21 December 2022 / Published: 25 December 2022
(This article belongs to the Special Issue Medicinal Plants and Natural Products in South America)

Abstract

:
Vouacapoua americana (Fabaceae) is an economically important tree in the Amazon region and used for its highly resistant heartwood as well as for medicinal purposes. Despite its frequent use, phytochemical investigations have been limited and rather focused on ecological properties than on its pharmacological potential. In this study, we investigated the phytochemistry and bioactivity of V. americana stem bark extract and its constituents to identify eventual lead structures for further drug development. Applying hydrodistillation and subsequent GC-MS analysis, we investigated the composition of the essential oil and identified the 15 most abundant components. Moreover, the diterpenoids deacetylchagresnone (1), cassa-13(14),15-dien-oic acid (2), isoneocaesalpin H (3), (+)-vouacapenic acid (4), and (+)-methyl vouacapenate (5) were isolated from the stem bark, with compounds 2 and 4 showing pronounced effects on Methicillin-resistant Staphylococcus aureus and Enterococcus faecium, respectively. During the structure elucidation of deacetylchagresnone (1), which was isolated from a natural source for the first time, we detected inconsistencies regarding the configuration of the cyclopropane ring. Thus, the structure was revised for both deacetylchagresnone (1) and the previously isolated chagresnone. Following our works on Copaifera reticulata and Vatairea guianensis, the results of this study further contribute to the knowledge of Amazonian medicinal plants.

1. Introduction

Vouacapoua americana Aubl. (Fabaceae—Caesalpinioideae) is one of four species of the genus Vouacapoua and is distributed throughout the Amazon region, including Brazil, Guyana, French Guiana, Suriname, and Venezuela, where it is referred to as acapu (Brazil) or wacapou (French Guiana, Suriname) [1,2,3]. It is a tree of up to 40 m in height with a stem diameter of up to 100 cm and is appreciated for its durable and highly resistant heartwood, which makes it an important source for all types of heavy-duty constructions [2,4]. The plant is also used for medicinal purposes; decoctions of the stem bark are applied as an astringent, antiseptic, and fortifier and are used for the treatment of diarrhea, gastric ulcers, hemorrhoids, spinal pain, and ailments of the liver [3,5,6].
Despite the ethnomedical usage of V. americana, bioactivity studies so far have only focused on the species’ phytotoxic and fungitoxic potential [7,8]. Thereby, aqueous extracts of the stem bark showed allelopathic activity, inhibiting germination and primary root elongation of pasture weeds Mimosa pudica and Urena lobata [7]. Since a follow-up study found the aqueous extract to contain no organic compounds but high concentrations of inorganic ions, the allelopathic effects were attributed to saline stress [8]. Similarly, investigations on the phytochemistry of V. americana have been scarce, with only three reported chemical structures so far [9,10,11]. Spoelstra [9] reported the presence of sesquiterpenes and sesquiterpene alcohols, as well as one crystalline substance in the benzene extract of V. americana bark, which was later identified as (+)-methyl vouacapenate (5) together with the corresponding free acid (4) (Figure 1) [10]. Another diterpenoid was reported by Kido et al. [11], who isolated cassa-13(14),15-dien-oic acid (2) together with the two aforementioned compounds.
As part of our ongoing research on Amazonian medicinal plants [12,13,14,15], we investigated the phytochemical profile of V. americana stem bark leading to the identification of the essential oil composition and the isolation of five diterpenoids (15, Figure 1), of which 1 was isolated from a natural source for the first time. In addition, we evaluated the isolated metabolites for their bioactivity potential towards a small panel of antimicrobial and cytotoxicity assays.

2. Results and Discussion

2.1. Essential Oil Composition

In the first step, the essential oil composition of V. americana stem bark was evaluated. Therefore, 5 g of dry plant material was ground and hydrodistilled by the method of the European Pharmacopeia [16]. The distillate was subsequently analyzed by GC-MS, using the Adams method [17] and a comparison of retention indices. Additionally, MS spectra were matched with spectra from the Adams and NIST databases. All compounds showing a relative content of more than 0.2%, a deviation of retention indices of less than 10, and (reversed) similarity indices of more than 700 are listed in Table 1.
Altogether, 14 sesquiterpenes and one diterpene ester (5) were found in the respective concentration and could be unambiguously identified. Interestingly, the diterpenoid (5) amounted to three-quarters of the distillate, whereas the sum of sesquiterpenes was below 25%. This ratio is in accordance with the results obtained by Spoelstra [9], who found a benzene extract to contain approximately 1.5% of volatiles and 3–3.5% of a crystalline substance after fractionation with vacuum distillation or high vacuum distillation, respectively.
In addition, Spoelstra reported the presence of cadinene and sesquiterpene alcohols, which is also supported by our results and which we could further specify. Of the volatile fraction, δ-cadinene was found to be the most dominant sesquiterpene with a concentration of 8.3%, followed by α-calacorene and α-muurolene as well as sesquiterpene alcohols τ-muurolol and α-cadinol, all showing amounts between 3 and 4%. Other sesquiterpenes with noteworthy concentrations were β-caryophyllene, γ-muurolene, and trans-cadina-1,4-diene, with concentrations of more than 2%.

2.2. Isolation and Structure Elucidation

In the next step, V. americana stem bark was extracted with methanol on a preparative scale (980 g of plant material, 6 L of solvent). The crude extract was further separated by liquid-liquid-extraction, column chromatography, and semi-preparative HPLC to afford five compounds, which were investigated by mass spectrometry and NMR spectroscopy and for their optical rotation values. After comparison of the obtained data with the values reported in the literature, compounds 2, 4, and 5 were identified as cassa-13(14),15-dien-oic acid (2), (+)-vouacapenic acid (4), and (+)-methyl vouacapenate (5), which were previously reported for V. americana [9,10,11]. Compound 3 was not described for V. americana but has been isolated from tara (Caesalpinia spinosa) and named isoneocaesalpin H [18].
Compound 1 (deacetylchagresnone) was isolated as a white powder, and its molecular formula was deduced as C20H32O3 based on HRESIMS measurements (Figure S1). Analysis of the NMR data (Table 2, Figures S2–S7) indicated 20 carbon resonances, corresponding to three methyl groups (δC 27.0, 14.8, and 14.1), eight methylene groups (δC 65.2, 62.4, 38.1, 36.5, 35.5 (2C), 22.1, and 18.2), five methine groups (δC 57.0, 55.2, 38.3, 37.2, and 36.8), three quaternary carbons (δC 38.5, 37.2, and 33.5), and one carbonyl carbon (δC 211.4).
In positions 1–8, carbon shift values of compound 1 were similar to those of the other isolated compounds (Table S1), thus also suggesting a diterpene scaffold. However, except for the carbonyl group, the NMR data of 1 neither showed alkene double bonds nor a carboxyl group in position 4, as observed for the other isolated constituents (Figure 1, Tables S1 and S2). Instead, compound 1 was substituted with a hydroxymethylene group in this position as indicated by the characteristic shift values of 65 (13C) and 3.4 to 3.7 (1H) ppm, respectively, as well as HMBC correlations to C-3, C-4, and C-18. NOESY correlations to H-2 and CH3-20, furthermore, confirmed the hydroxymethylene group to be in β-position (Figure 2).
HMBC couplings of the carbonyl group to both H-11 protons and two methine groups indicated position 12 for this feature. More interestingly, the carbonyl group was also coupling to the protons of the CH3-17 methyl group, thus suggesting the diterpenoid to be of a pimarane-type in contrast to the before observed cassane-type diterpenes. This was corroborated by the missing signal splitting of CH3-17. The corresponding ethyl group was found to be hydroxylated in the terminal position and, moreover, to be linked to the C-14 carbon, thus forming a cyclopropane ring.
A literature search for corresponding compounds yielded the hydrolyzation product of chagresnone, which was previously isolated from Myrospermum frutescens (Fabaceae) [19]. The NMR data of compound 1 matched perfectly with the reported values. However, the proposed α-orientation of the cyclopropyl group, which was not based on respective NOESY correlations, was not supported by our experiments. For example, no correlations were observed between H-8 and neighboring H-14 or CH3-17, respectively. In contrast, NOESY correlations supported the β-orientation of the cyclopropyl group, as demonstrated by the coupling of H-15 with H-8 and H-11a or the coupling of H-14 with H-7b, respectively (Figure 2). Therefore, the cyclopropyl group had to be β-oriented, and H-14, as well as CH3-17, had to be α-oriented instead, as was the CH2-16 methylene group. Thus, the structure of compound 1 was established as (14R,16R,18S)-16,18-dihydroxy-14,15-cyclopimaran-12-one.

2.3. Bioactivity Assessments

All isolated compounds were subjected to a panel of antimicrobial and cytotoxicity assays (Tables S3–S5). Studies on cytotoxicity comprised of the following cell lines: breast cancer (MB-231), colon cancer (HCT-116), lung cancer (A-549), melanoma (A-375), and non-cancerous keratinocytes (HaCaT). Antimicrobial activity assessments were carried out on human pathogenic yeast/fungi (Candida albicans, Cryptococcus neoformans, Trichophytum rubrum) as well as on the ESKAPE panel comprised of highly virulent human pathogenic bacteria. This included the gram-positive bacteria Methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecium, and the gram-negative bacteria Acinetobacter baumanii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa.
At a test concentration of 100 µM, none of the five compounds exhibited noteworthy cytotoxicity (Table S3). The highest effect was observed for compound 5, which showed 60% growth inhibition against both A-375 and HaCaT cell lines. The activity of 5 against other cell lines and of other compounds was significantly below 50%. The same picture was observed against fungi and gram-negative bacteria, with inhibition rates below 50% and, thus, IC50 values above 100 µM (Tables S4 and S5). However, two compounds were found to be active against gram-positive bacteria (Table S5). Compounds 2 and 4 inhibited the growth of MRSA with IC50 values of 13.5 µM and 12.0 µM, respectively (Table 3). (+)-Vouacapenic acid (4) also displayed activity against E. faecium, with an IC50 value of 8.3 µM, thus being active against both gram-positive test strains.
The pronounced activity of some diterpene acids is well known, and phytochemical research on resins and other sources of this particular compound class, therefore, is still relevant. Caesalsappanine J, which was isolated from Caesalpinia sappan, shows strong structural similarities to compound 3 and exhibited antiproliferative activity against the KB cell line with an IC50 value of 7.4 µM [20]. In addition, caesalsappanins O, P, and Q displayed moderate effects against MFC-7 and HCT-116 cells [21]. Other reported cytotoxic diterpenoids from C. sappan are caesappins A and B, with weak to moderate effects against HeLa and HepG-2 cells [22]. Cassane-type diterpenoids with more pronounced effects were isolated from Erythrophleum fordii (erythroformin A and B) and Euphorbia fischeriana (euphkanoid H) [23,24]. While erythroformins A and B affected lung cancer cell lines A-549, NCI-H1975, and NCI-H1229 with IC50 values in the range of 0.4 to 1.4 µM [23], euphkanoid H showed activity on HEL cells with an IC50 value of 3.2 µM [24]. However, in contrast to the diterpenoids isolated in the present study, the latter three compounds bore a nitrogen atom. E. fischeriana, furthermore, yielded a series of moderately (IC50 values of 10–20 µM) cytotoxic ent-abietane-type diterpenoids, such as euphonoids A–D with activity against C4-2B cells [25], fischerianoids A and B with effects on MM-231 and Hep3B cells [26], or difischenoid A showing growth inhibition of HeLa cells [27]. The latter study also yielded difischenoid B, which exhibited stronger effects on HeLa cells (IC50 value of 3.75 µM) and was, moreover, active on MCF-7 cells (IC50 value of 9.31 µM). Phytochemical investigation of the Chinese mangrove Ceriops tagal yielded the cytotoxic pimarane-type diterpene tagalon C and the isopimarane-type diterpene tagalon D [28]. Both compounds were effective against the breast cancer cell line MT-1, with IC50 values of 3.75 µM and 8.07 µM, respectively.
Also, with regard to antimicrobial activities, compounds of various diterpene types were found effective. Isopimaric acid and abietic acid, for example, were found to inhibit the growth of MRSA with MIC values of 32 to 64 µg/mL, while carnosic acid was found to modulate drug resistance via the inhibition of efflux pumps [29,30]. In a previous study on the oleoresin of Copaifera reticulata, we identified five compounds of three different diterpene types with significant activity against both MRSA and E. faecium with IC50 values of 10.7 to 2.5 µM and 9.3 to 1.6 µM, respectively [13]. Thereby, the activity increased with the lipophilicity of the tested components. (–)-Polyalthic acid, the major diterpenoid in C. reticulata and the only isolated diterpene bearing a furyl moiety, was also effective against Trichophytum rubrum, T. mentagrophytes, and Cryptococcus neoformans [14]. In contrast to the antifungal activity, the antibacterial effects completely vanished upon esterification or amidation, a fact that was also observed in the present study. While (+)-vouacapenic acid (4) showed pronounced activity on both gram-negative bacteria, its corresponding methyl ester (5) did not exhibit any effects at all (Table 3). However, in the case of isoneocaesalpin H (3), antibacterial effects are missing, despite the structural similarity to (+)-vouacapenic acid (4) and a carboxyl group in position 4 (Figure 1). If the missing activity is also due to higher polarity (caused by one additional hydroxy group in position and one oxo group in position (16) cannot be excluded and is at least corroborated by the activity of the more lipophilic but less similar compound 2. The same question is even more difficult to answer for deacetylchagresnone (1), which shows higher polarity than the active compounds as well as a hydroxymethylene group instead of a carboxylic acid in position 4. Moreover, compound 1 displays a different diterpene type, namely a pimarane derivative. Therefore, additional derivatives must be isolated in order to have sufficient data for detailed structure-activity-relationship studies. Hence, the discovery of deacetylchagresnone (1), which has not been isolated from nature before, and the identification of two potent antibacterials, render V. americana an interesting source for the discovery of further bioactives. The activity against E. faecium, one of the major pathogens for nosocomial infections, is of particular interest, as comparably few inhibiting natural products have been identified so far, while vancomycin resistances continue to decrease [31].

3. Materials and Methods

3.1. General Experimental Procedures

Thin layer chromatography was performed with precoated TLC plates (Silica gel 60 F254 Merck, Darmstadt, Germany) using dichloromethane–methanol (19:1) as eluent and vanillin sulfuric acid as spraying reagent. Flash chromatography was carried out manually with a glass column (500 × 235 mm) or with a Büchi PrepChrom C-700 chromatograph using a FlashPure EcoFlex Silica Gel SL cartridge (40 g, irregular 40–63 µM particle size, Büchi Labortechnik GmbH, Essen, Germany). Preparative MPLC was conducted on a Büchi PrepChrom with a Büchi PrepChrom HPLC column (C18, 15 µM, 250 × 30.0 mm), and size exclusion chromatography was performed with Sephadex LH-20 (GE Healthcare AB, Uppsala, Sweden). HPLC-DAD-ELSD analyses were accomplished on a VWR-Hitachi Chromaster Ultra RS equipped with a 6170 binary pump, 6270 autosampler, 6310 column oven, 6430 diode array detector, and a VWR 100 evaporative light scattering detector (VWR International GmbH, Darmstadt, Germany). UHPLC-MS analyses were carried out on a Shimadzu Nexera 2 liquid chromatograph connected to an LCMS 8030 triple quadrupole mass spectrometer using electrospray ionization (Shimadzu, Kyoto, Japan). A Phenomenex Luna Omega C18 column (100 × 2.1 mm, 1.6 µM particle size, Phenomenex, Aschaffenburg, Germany) was employed for the analysis of extracts, fractions, and pure compounds with 0.1% formic acid in water (A) and acetonitrile (B) and the following gradient: 35% B to 95% B in 30 min, to 95% B in 15 min. Post run: 10 min. Flow rate: 0.2 mL/min, column temperature: 35 °C. Hydrodistillation was accomplished as described in the European Pharmacopeia (10th edition) using 5 g of plant material and 200 mL of water. Distillation was running for 3 h with a rate of 3 mL/min. 500 µL of xylene was used to collect the essential oil, which was diluted to 1 mL with xylene and injected into the GC-MS/MS apparatus with a split of 1:10. Analyses were performed on a Trace 1310 gas chromatograph equipped with an SSL and PTV inlet and a TSQ Duo mass spectrometer and a TG-5SilMS (30 m × 0.25 mm × 0.25 µm) (Thermo Scientific, Bremen, Germany). The following parameters were applied: 60 °C, 3 °C/min to 246 °C, and hold for 8 min. MS parameters: Fullscan 50–500 m/z. Compounds were identified using the NIST database version 2020 and the Adams enhanced database (4th edition), as well as a comparison of retention indices. HRESIMS spectra were recorded on a Q-Exactive Plus spectrometer, and specific rotation of the compounds was measured on a Jasco P-2000 polarimeter (Jasco, Pfungstadt, Germany). 1D (1H, 13C) and 2D (HSQC, HMBC, COSY, NOESY) NMR spectra were recorded on a Bruker Avance III 400 NMR spectrometer operating at 400 MHz for the proton channel and 100 MHz for the 13C channel with a 5 mm PABBO broadband probe with a z gradient unit at 293 K (Bruker BioSpin GmbH, Rheinstetten, Germany). A Bruker Avance 600 MHz spectrometer was used for measurements of compound 1. Reference shift values were 7.26 (1H) and 77.36 (13C) for chloroform, as well as 3.31 (1H) and 49.15 ppm (13C) for methanol, respectively. Conventional 5 mm NMR sample tubes were obtained from Rototec-Spintec GmbH, Griesheim, Germany. Alkane standard (C7–C40) and LC-MS grade formic acid were purchased from Sigma Aldrich Co., St. Louis, MO, USA. LC-MS grade acetonitrile and water, gradient grade methanol, and other (analytical grade) solvents were obtained from VWR International GmbH, Darmstadt, Germany. Water used for isolation was doubly distilled in-house. Chloroform-d1 (99.50%, Lot T2811, Batch 0920) and methanol-d4 (99.80%, Lot P3021, Batch 1016B) for NMR spectroscopy were purchased from Euriso-top GmbH, Saarbrücken, Germany.

3.2. Plant Material

Stem bark of Vouacapoua americana was collected in February 2020 in the municipality of Serra do Navio, Amapá, at the coordinates 00°53′20.9″ N/052°00′06.5″ W and identified by J.F.O. Segovia. A voucher specimen is kept in the Dr. J.F.O. Segovia collection of the herbarium of the Brazilian Agricultural Research Corporation (EMBRAPA) in Macapá, under the registration number ESK-03. The plant species was registered for access to the genetic heritage in SisGen with process no. 00.038.174/0001-43.

3.3. Extraction and Isolation

980 g of dried and ground stem bark were extracted five times with 1.2 L of methanol using ultra-sonication for 15 min and subsequent maceration for at least 12 h. The solvent was evaporated under reduced pressure at a temperature of 35 °C to afford 237 g of crude extract, which was then partitioned between water and dichloromethane. The dichloromethane fraction (27.0 g) was subjected to column chromatography (500 × 235 mm) using silica gel (800 g) as the stationary phase, and the following gradient of n-hexane–dichloromethane–methanol: 75:25:0 (2 L), 50:50:0 (2 L), 25:75:0 (2 L), 0:100:0 (2 L), 0:98:2 (2 L), 0:96:4 (2 L), 0:94:6 (1 L), 0:92:8 (1 L), 0:90:10 (1 L), and 0:0:100 (2 L). Of the resulting 14 fractions, fraction 5 yielded 2.22 g of compound 5 after crystallization from acetone. Fraction 7 yielded 2.40 g of compound 2, and fraction 10 gave 1.88 g of compound 4 after crystallization from acetone. Fractions 12 (233 mg) and 13 (984 mg) were combined and subjected to silica gel flash chromatography with the following gradient of n-hexane–ethyl acetate–methanol: 100:0:0 in 10 min to 50:50:0, in 10 min to 40:40:20, in 10 min to 0:0:100, in 30 min to 0:0:100. Of the resulting five fractions, the latter fraction (289 mg) was separated by Sephadex LH-20 column chromatography [acetone-methanol (1:1)]. Fraction 4 (out of 7) was further separated by semi-preparative HPLC to afford 9.22 mg of compound 1 and 13.8 mg of compound 3.
Deacetylchagresnone (1): White powder; m.p. 80.2 °C; [α]25D + 199 (c 2.85, methanol), HRESIMS (positive) m/z 353.2658 [M + MeOH + H]+ (calcd for C21H37O4, 353.2692) (Figure S1); 1H NMR (CDCl3, 600 MHz) and 13C NMR (CDCl3, 150 MHz) see Table 2 and Figures S2−S7.

3.4. Biological Activity

Antibacterial and anti-yeast activity was determined as described by Çiçek et al. [14]. The bacteria were cultivated in TSB medium (1.2% tryptic soy broth, 0.5% NaCl), except E. faecium, which was cultivated in M92 medium (3% trypticase soy broth, 0.3% yeast extract, pH 7.0–7.2). The cultivation of C. albicans and C. neoformans took place in M186/3 (0.3% glucose, 0.17% peptone from soymeal, 0.1% malt extract, 0.1% yeast extract). Overnight cultures of the test organisms were prepared and diluted to an optical density (600 nm) of 0.01–0.03. To prepare the assay, the test samples (20 mg/mL DMSO stock solution) were dissolved in medium and transferred into a 96-well microtiter plate, and 200 µL of the cell suspension cultures were added to each well. The final assay concentration of the substances was 100 µg/mL, and the final DMSO concentration was 0.5% (negative control). For IC50 determination, a dilution series was prepared, and the IC50 value was calculated by Excel or GraphPad Prism as the concentration that shows 50% inhibition of viability on the basis of a negative control.
Activity assays against dermatophytic fungi and cytotoxicity assays were performed as described by Pfeifer Barbosa et al. [13]. Trichophyton rubrum I/95 (patient isolates from Kiel University Hospital) were cultivated for two weeks on Sabouraud agar (1% peptone, 2% glucose, 1.5% agar-agar, pH 5.6). A suspension of 5 × 104 spores/mL Sabouraud medium was prepared and added to each well of a microplate containing the test samples, which were transferred as described before (antibacterial assay). After incubation for 72 h at 28 °C and 120 rpm, the optical density at 600 nm was measured using the microplate reader. The resulting values were compared with a positive (clotrimazole) and a negative control (0.5% DMSO) on the same plate.
For cytotoxicity assays, HEP-G2, HT-29, and HaCaT cells were cultivated in RPMI medium, A549 and MDA-MB-231 cells in DMEM:Ham’s F12 medium (1:1) supplemented with 15 mM HEPES, and A-375 and HCT-116 cells were cultivated in DMEM medium supplemented with 4.5 g/L D-glucose and 110 mg/L sodium pyruvate. All media were supplemented with L-glutamine, 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin. The cultures were maintained at 37 °C under a humidified atmosphere and 5% CO2. The cell lines were transferred every 3 or 4 days. For the experimental procedure, cells were seeded in 96-well plates at a concentration of 10,000 cells per well in RPMI. After 24 h incubation, the medium was removed, and 100 µL of the test sample was adjusted to a final concentration of 100 µg/mL by diluting with a growth medium. Doxorubicin, as a standard therapeutic drug, was used as a positive control, and DMSO (0.5%) was used as a negative control.

4. Conclusions

In the present study, we conducted a detailed phytochemical analysis of Vouacapoua americana stem bark extract, leading to the elucidation of the essential oil composition and the isolation of five diterpenoids. The isolated substances were subsequently tested in a panel of antimicrobial and cytotoxicity assays, revealing pronounced effects for cassa-13(14),15-dien-oic acid (2) and (+)-vouacapenic acid (4) against Methicillin-resistant Staphylococcus aureus and Enterococcus faecium, respectively. Additionally, one of the compounds was isolated from a natural source for the first time and identified as deacetylchagresnone (1). We detected inconsistencies in the structure elucidation of the related compound chagresnone leading to the wrong assignment of the cyclopropane orientation, which we clarified thanks to detailed NOESY correlations. Following our previous work on Copaifera reticulata and Vatairea guianensis, the present study is another contribution to the chemical composition and bioactivity of Amazonian medicinal plants.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/plants12010099/s1, Figure S1: HRESIMS spectrum of compound 1; Figures S2–S7: 1D and 2D NMR spectra of compound 1; Table S1: 13C NMR data of compounds 25; Table S2: 1H NMR data of compounds 25; Table S3: Cytotoxic effects of compounds 15; Table S4: Antifungal effects of compounds 15; Table S5: Antibacterial effects of compounds 15.

Author Contributions

Conceptualization, S.S.Ç.; methodology, S.S.Ç.; investigation, S.S.Ç., A.L.P.B., A.W.-S., J.F.O.S. and C.Z.; resources, R.M.B., F.S., C.Z., I.K. and D.T.; data curation, S.S.Ç., A.L.P.B. and A.W.-S.; writing—original draft preparation, S.S.Ç.; writing—review and editing, S.S.Ç. and D.T.; supervision, S.S.Ç.; project administration, S.S.Ç. and I.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was in parts funded by the Federal District Funding Agency/FAP DF, Brazil.

Data Availability Statement

Data are available from the authors upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Vouacapoua Aubl. Available online: http://www.worldfloraonline.org/taxon/wfo-4000040438 (accessed on 14 November 2022).
  2. Cruz, E.D.; Gonçalves Pereira, A. Germinaçao de sementes de espécies amazônicas: Acapu (Vouacapoua americana Aubl.). Comun. Técnico Embrapa 2016, 288, 1–4. [Google Scholar]
  3. Rios, M.N.D.S.; Pastore Junior, F. Plantas da Amazônia: 450 Espécies de Uso Geral; Universidade de Brasília: Brasilia, Brazil, 2011; pp. 1433–1442. [Google Scholar]
  4. Kukachka, B.F. Properties of Imported Tropical Woods; U.S.D.A. Forest Service. Forest Products Laboratory: Madison, VI, USA, 1970; p. 49.
  5. Leite, A.M.C.; Lleras, E. Áreas prioritárias na Amazônia para conservaçao dos recursos genéticos de espécies florestais nativas: Fase preliminar. Acta Bot. Bras. 1993, 7, 61–94. [Google Scholar] [CrossRef] [Green Version]
  6. Pinto, L.N. Plantas Medicinais Utilizadas por Comunidades Domunicípio de Igarapé-Miri, Pará: Etnofarmácia do Município DeIgarapé-Miri-PA. Master’s Thesis, Universidade Federal do Pará, Belém, Brazil, 2008. [Google Scholar]
  7. Souza Filho, A.P.S.; Alves, S.M. Potencial alelopático de plantas de acapu (Vouacapoua americana): Efeitos sobre plantas daninhas de pastagens. Planta Daninha 2000, 18, 435–441. [Google Scholar] [CrossRef] [Green Version]
  8. Paracampo, N.E.; Müller, A.H.; Alves, S.D.; Filho, A.P.; Guilhon, G.M.; Aruda, M.S.; Santos, L.D.; Arruda, A.C. Atividade fitotóxica e fungitóxica de extratos de Vouacapoua cf americana Aublet (Leg.-Caesalp.), essência florestal Nativa da Amazônia. Rev. Ciências Agrárias 2009, 52, 9–22. [Google Scholar]
  9. Spoelstra, D.B. Ueber Das Aetherische Oel Und Den Krystallisierten Ester Aus Dem Kernholze von Vouacapoua americana Aubl. Recl. Trav. Chim. Pays-Bas 1930, 49, 226–236. [Google Scholar] [CrossRef]
  10. King, F.E.; Godson, D.H.; King, T.J. The Chemistry of extractives from hardwoods. Part XXII. The Structure of Diterpenes from Vouacapoua Species. J. Chem. Soc. 1955, 1117–1125. [Google Scholar] [CrossRef]
  11. Kido, T.; Taniguchi, M.; Baba, K. Diterpenoids from Amazonian Crude Drug of Fabaceae. Chem. Pharm. Bull. 2002, 51, 207–208. [Google Scholar] [CrossRef] [Green Version]
  12. Çiçek, S.S.; Pfeifer Barbosa, A.L.; Girreser, U. Quantification of Diterpene Acids in Copaiba Oleoresin by UHPLC-ELSD and Heteronuclear Two-Dimensional QNMR. J. Pharm. Biomed. Anal. 2018, 160, 126–134. [Google Scholar] [CrossRef]
  13. Barbosa, A.L.P.; Wenzel-Storjohann, A.; Barbosa, J.D.; Zidorn, C.; Peifer, C.; Tasdemir, D.; Çiçek, S.S. Antimicrobial and Cytotoxic Effects of the Copaifera reticulata Oleoresin and Its Main Diterpene Acids. J. Ethnopharmacol. 2019, 233, 94–100. [Google Scholar] [CrossRef]
  14. Çiçek, S.S.; Wenzel-Storjohann, A.; Girreser, U.; Tasdemir, D. Biological activities of two major copaiba diterpenoids and their semi-synthetic derivatives. Rev. Bras. Farmacogn. 2020, 30, 18–27. [Google Scholar] [CrossRef] [Green Version]
  15. Çiçek, S.S.; Galarza Pérez, M.; Wenzel-Storjohann, A.; Bezerra, R.M.; Segovia, J.F.O.; Girreser, U.; Kanzaki, I.; Tasdemir, D. Antimicrobial prenylated isoflavones from the leaves of the Amazonian medicinal plant Vatairea guianensis Aubl. J. Nat. Prod. 2022, 85, 927–935. [Google Scholar] [CrossRef] [PubMed]
  16. European Directorate for the Quality of Medicines & Health Care (EDQM). European Pharmacopoeia, 10th ed.; European Directorate for the Quality of Medicines & Health Care (EDQM): Strasbourg, France, 2020. [Google Scholar]
  17. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry, 4th ed.; Allured Publishing Corporation: Carol Stream, IL, USA, 2007. [Google Scholar]
  18. He, D.; Li, Y.; Tang, H.; Ma, R.; Li, X.; Wang, L. Six new cassane diterpenes from the twigs and leaves of Tara (Caesalpinia spinosa Kuntze). Fitoterapia 2015, 105, 273–277. [Google Scholar] [CrossRef] [PubMed]
  19. Torres-Mendoza, D.; Ureña González, L.D.; Ortega-Barría, E.; Coley, P.D.; Kursar, T.A.; Capson, T.L.; McPhail, K.; Cubilla-Rios, L. Novel Cassane and Cleistanthane Diterpenes from Myrospermum frutescens:  Absolute Stereochemistry of the Cassane Diterpene Series. J. Nat. Prod. 2004, 67, 1711–1715. [Google Scholar] [CrossRef]
  20. Ma, G.; Wu, H.; Chen, D.; Zhu, N.; Zhu, Y.; Sun, Z.; Li, P.; Yang, J.; Yuan, J.; Xu, X. Antimalarial and Antiproliferative Cassane Diterpenes of Caesalpinia sappan. J. Nat. Prod. 2015, 78, 2364–2371. [Google Scholar] [CrossRef] [PubMed]
  21. Wu, H.-F.; Zhu, Y.-D.; Sun, Z.-H.; Yuan, J.-Q.; Wei, H.; Zhang, X.-P.; Tian, Y.; Yang, J.-S.; Ma, G.-X.; Xu, X.-D. Norcassane- and Cassane-Type Furanoditerpenoids from the Seeds of Caesalpinia sappan. Fitoterapia 2014, 98, 22–26. [Google Scholar] [CrossRef] [PubMed]
  22. Yuanting, J.; Ruikang, H.; Yang, L.; Hanqiao, L. Two New Cassane-Type Diterpenoids from the Seeds of Caesalpinia sappan. Nat. Prod. Res. 2022, 36, 2078–2084. [Google Scholar] [CrossRef]
  23. Ha, M.T.; Tran, M.H.; Phuong, T.T.; Kim, J.A.; Woo, M.H.; Choi, J.S.; Lee, S.; Lee, J.H.; Lee, H.K.; Min, B.S. Cytotoxic and Apoptosis-Inducing Activities against Human Lung Cancer Cell Lines of Cassaine Diterpenoids from the Bark of Erythrophleum fordii. Bioorg. Med. Chem. Lett. 2017, 27, 2946–2952. [Google Scholar] [CrossRef]
  24. Chen, B.-L.; Zhu, Q.-F.; Zhang, X.; Lin, Y.; Long, Q.-D.; Liu, W.-L.; Yan, X.-L. An Unusual Indole-Diterpenoid with C-17 Norcassane Skeleton from Euphorbia fischeriana Induces HEL Cell Cycle Arrest and Apoptosis. Fitoterapia 2022, 159, 105195. [Google Scholar] [CrossRef]
  25. Yan, X.-L.; Zhang, J.-S.; Huang, J.-L.; Zhang, Y.; Chen, J.-Q.; Tang, G.-H.; Yin, S. Euphonoids A-G, Cytotoxic Diterpenoids from Euphorbia fischeriana. Phytochemistry 2019, 166, 112064. [Google Scholar] [CrossRef]
  26. Li, M.; He, F.; Zhou, Y.; Wang, M.; Tao, P.; Tu, Q.; Lv, G.; Chen, X. Three New Ent-Abietane Diterpenoids from the Roots of Euphorbia fischeriana and Their Cytotoxicity in Human Tumor Cell Lines. Arch. Pharm. Res. 2019, 42, 512–518. [Google Scholar] [CrossRef] [Green Version]
  27. Wei, J.-C.; Gao, Y.-N.; Wang, D.-D.; Zhang, X.-Y.; Fan, S.-P.; Bao, T.-R.-G.; Gao, X.-X.; Hu, G.-S.; Wang, A.-H.; Jia, J.-M. Discovery of Highly Oxidized Abietane Diterpenoids from the Roots of Euphorbia Fischeriana with Anti-Tumor Activities. Chin. J. Chem. 2021, 39, 2973–2982. [Google Scholar] [CrossRef]
  28. Zhang, X.; Li, W.; Shen, L.; Wu, J. Four New Diterpenes from the Mangrove Ceriops tagal and Structure Revision of Four Dolabranes with a 4,18-Epoxy Group. Fitoterapia 2018, 124, 1–7. [Google Scholar] [CrossRef] [PubMed]
  29. Smith, E.; Williamson, E.; Zloh, M.; Gibbons, S. Isopimaric Acid from Pinus nigra Shows Activity against Multidrug-Resistant and EMRSA Strains of Staphylococcus aureus. Phytotherapy Res. 2005, 19, 538–542. [Google Scholar] [CrossRef] [PubMed]
  30. Oluwatuyi, M.; Kaatz, G.W.; Gibbons, S. Antibacterial and Resistance Modifying Activity of Rosmarinus officinalis. Phytochemistry 2004, 65, 3249–3254. [Google Scholar] [CrossRef]
  31. Boucher, H.W.; Talbot, G.H.; Bradley, J.S.; Edwards, J.E.; Gilbert, D.; Rice, L.B.; Scheld, M.; Spellberg, B.; Bartlett, J. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 48, 1–12. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of isolated compounds deacetylchagresnone (1), cassa-13(14),15-dien-oic acid (2), isoneocaesalpin H (3), (+)-vouacapenic acid (4), and (+)-methyl vouacapenate (5).
Figure 1. Chemical structures of isolated compounds deacetylchagresnone (1), cassa-13(14),15-dien-oic acid (2), isoneocaesalpin H (3), (+)-vouacapenic acid (4), and (+)-methyl vouacapenate (5).
Plants 12 00099 g001
Figure 2. Important NOESY correlations observed for compound 1.
Figure 2. Important NOESY correlations observed for compound 1.
Plants 12 00099 g002
Table 1. Composition of the essential oil identified by GC-MS analysis and retention indices. (+)-methyl vouacapenate (5) was retrospectively identified by comparison with the isolated substance.
Table 1. Composition of the essential oil identified by GC-MS analysis and retention indices. (+)-methyl vouacapenate (5) was retrospectively identified by comparison with the isolated substance.
Compound NametR 1 [min]ToC 2 [%]CoS 3 [%]RIexp 4RIlit 5SI 6RSI 7ID 8
α-copaene19.560.231.013751374856874RI, MS
β-caryophyllene21.300.632.714181417906910RI, MS
rotundene22.950.351.514591457812901RI, MS
γ-muurolene23.480.602.614731478925933RI, MS
α-muurolene24.420.713.014961500924931RI, MS
γ-cadinene24.960.311.315101513894911RI, MS
δ-cadinene25.211.948.315161522872900RI, MS
trans-cadina-1,4-diene25.710.532.315291533894943RI, MS
α-calacorene26.010.913.915371544891933RI, MS
caryophyllene oxide27.530.281.215771582837848RI, MS
τ-muurolol29.870.703.016401640868880RI, MS
α-cadinol30.310.693.016511652856865RI, MS
cadalene30.900.401.716681675750842RI, MS
amorpha-4,9-dien-2-ol31.880.271.216941700771785RI, MS
(+)-methyl vouacapenate (5)56.6876.67 2446Ref.
1 tR: Retention time on the TG-5SilMS GC column. 2ToC: Concentration relative to all compounds in the distillate given in percent. 3CoS: Concentration relative to sesquiterpenes found in the distillate given in percent. 4RIexp: Retention index determined relative to n-alkanes (C10-C25). 5 RIlit: Retention index reported by Adams [17]. 6 SI: Similarity index of mass spectra. 7 RSI: Reversed similarity index of mass spectra. 8 ID: Methods used for identification. RI: Comparison of Retention indices, MS: Comparison to MS databases, Ref.: Comparison with reference standard.
Table 2. 1H (600 MHz) and 13C (150 MHz) NMR data of compound 1 in CDCl3 (δ in ppm, J in Hz).
Table 2. 1H (600 MHz) and 13C (150 MHz) NMR data of compound 1 in CDCl3 (δ in ppm, J in Hz).
Position1H NMR13C NMR
10.89 m, 1.60 dt (3.9, 12.7)38.1, CH2
21.46 (2H) m18.2, CH2
30.93 m, 1.80 m35.5, CH2
4 38.5, C
51.03 dd (2.5, 12.7)55.2, CH
61.34 m, 1.78 m22.1, CH2
71.23 m, 2.05 m35.5, CH2
81.67 m36.8, CH
91.12 td (1.9, 11.7)57.0, CH
10 37.2, C
111.85 t (14.1), 2.20 dd (2.1, 14.3)36.5, CH2
12 211.4, C
13 33.5, C
141.01 dd (1.5, 12.9)38.3, CH
151.51 m37.2, CH
163.56 dd (7.8, 11.6), 3.79 dd (6.0, 11.7)62.4, CH2
171.23 s14.1, CH3
180.95 s27.0, CH3
193.42 d (10.9), 3.72 d (10.9)65.2, CH2
200.76 s14.8, CH3
Table 3. Antibacterial effects of compounds 15. The IC50 values are in µM. Positive controls (PC) were chloramphenicol (MRSA) and ampicillin (E. faecium), respectively.
Table 3. Antibacterial effects of compounds 15. The IC50 values are in µM. Positive controls (PC) were chloramphenicol (MRSA) and ampicillin (E. faecium), respectively.
12345PC
MRSA13.5 ± 5.612.0 ± 5.14.6 ± 0.1
E. faecium8.3 ± 1.30.6 ± 0.0
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Çiçek, S.S.; Pfeifer Barbosa, A.L.; Wenzel-Storjohann, A.; Segovia, J.F.O.; Bezerra, R.M.; Sönnichsen, F.; Zidorn, C.; Kanzaki, I.; Tasdemir, D. Chemical and Biological Evaluation of Amazonian Medicinal Plant Vouacapoua americana Aubl. Plants 2023, 12, 99. https://doi.org/10.3390/plants12010099

AMA Style

Çiçek SS, Pfeifer Barbosa AL, Wenzel-Storjohann A, Segovia JFO, Bezerra RM, Sönnichsen F, Zidorn C, Kanzaki I, Tasdemir D. Chemical and Biological Evaluation of Amazonian Medicinal Plant Vouacapoua americana Aubl. Plants. 2023; 12(1):99. https://doi.org/10.3390/plants12010099

Chicago/Turabian Style

Çiçek, Serhat Sezai, Anna Laís Pfeifer Barbosa, Arlette Wenzel-Storjohann, Jorge Federico Orellana Segovia, Roberto Messias Bezerra, Frank Sönnichsen, Christian Zidorn, Isamu Kanzaki, and Deniz Tasdemir. 2023. "Chemical and Biological Evaluation of Amazonian Medicinal Plant Vouacapoua americana Aubl" Plants 12, no. 1: 99. https://doi.org/10.3390/plants12010099

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop